Trek Financial LLC Purchases 13,041 Shares of Gilead Sciences, Inc. $GILD

Trek Financial LLC significantly increased its stake in Gilead Sciences, Inc. by 510.8% during the fourth quarter, purchasing an additional 13,041 shares to hold a total of 15,594 shares valued at approximately $1.914 million. This increased investment follows Gilead’s positive earnings report, where the company beat analyst expectations with $2.03 EPS and $6.96 billion in revenue, and announced a quarterly dividend of $0.82 per share. Analysts generally maintain a “Moderate Buy” rating for GILD, with an average price target of $157.04.

GILD-2%
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pinned